{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:59:11Z","timestamp":1782878351067,"version":"3.54.5"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1097\/md.0000000000000780","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T22:17:13Z","timestamp":1432246633000},"page":"e780","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence of Raynaud Phenomenon and Nailfold Capillaroscopic Abnormalities in Fabry Disease"],"prefix":"10.1097","volume":"94","author":[{"given":"Samuel","family":"Deshayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Auboire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Jaussaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lidove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Parienti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Triclin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Bienvenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Aouba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210226","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease.","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"R2-13-20210226","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.2174\/13816128113199990352","article-title":"Anderson-Fabry disease: a multiorgan disease.","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr Pharm Des"},{"key":"R3-13-20210226","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabrys disease.","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"R4-13-20210226","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening.","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R5-13-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","article-title":"A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance.","volume":"51","author":"Van der Tol","year":"2014","journal-title":"J Med Genet"},{"key":"R6-13-20210226","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmg.2009.072116","article-title":"Screening for Fabry disease in high-risk populations: a systematic review.","volume":"47","author":"Linthorst","year":"2010","journal-title":"J Med Genet"},{"key":"R7-13-20210226","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.08.010","article-title":"Prevalence of Fabry disease in stroke patients - a systematic review and meta-analysis.","volume":"23","author":"Shi","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R8-13-20210226","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1399-0004.2011.01718.x","article-title":"Fabry disease The New Great Imposter: results of the French Observatoire in Internal Medicine Departments (FIMeD).","volume":"81","author":"Lidove","year":"2012","journal-title":"Clin Genet"},{"key":"R9-13-20210226","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/qjmed\/hcq117","article-title":"Fabry disease: a review of current management strategies.","volume":"103","author":"Mehta","year":"2010","journal-title":"QJM"},{"key":"R10-13-20210226","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/GIM.0b013e3181f13b75","article-title":"Effects of enzyme replacement therapy in Fabry disease - a comprehensive review of the medical literature.","volume":"12","author":"Lidove","year":"2010","journal-title":"Genet Med"},{"key":"R11-13-20210226","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1172-8-47","article-title":"Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain.","volume":"8","author":"Rombach","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R12-13-20210226","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11916-013-0365-4","article-title":"Fabry disease: a rare cause of neuropathic pain.","volume":"17","author":"Biegstraaten","year":"2013","journal-title":"Curr Pain Headache Rep"},{"key":"R13-13-20210226","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00415-012-6800-3","article-title":"Small fibre neuropathy in Fabry disease.","volume":"260","author":"Bertelsen","year":"2013","journal-title":"J Neurol"},{"key":"R14-13-20210226","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.2174\/13816128113199990387","article-title":"Neurological complications of Anderson-Fabry disease.","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr Pharm Des"},{"key":"R15-13-20210226","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","article-title":"Fabry disease.","volume":"122","author":"Schiffmann","year":"2009","journal-title":"Pharmacol Ther"},{"key":"R16-13-20210226","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1111\/j.1468-1331.2011.03558.x","article-title":"Peripheral microcirculation dysfunction evaluated by computed tomography perfusion study in Fabry patients.","volume":"19","author":"Ro","year":"2012","journal-title":"Eur J Neurol"},{"key":"R18-13-20210226","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0248-8663(05)80422-9","article-title":"Le Raynaud de la maladie de Fabry. Interet de la capillaroscopie digitale. A propos de 3 cas.","volume":"14","author":"Bolla","year":"1993","journal-title":"Rev Medecine Interne"},{"key":"R19-13-20210226","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0923-1811(94)90024-8","article-title":"Capillary changes in angiokeratoma corporis diffusum Fabry.","volume":"7","author":"Jansen","year":"1994","journal-title":"J Dermatol Sci"},{"key":"R20-13-20210226","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/0971-6866.25298","article-title":"Capillaroscopy in Fabry disease: study of a family.","volume":"12","author":"Lopez-Rodriguez","year":"2006","journal-title":"Indian J Hum Genet"},{"key":"R21-13-20210226","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3233\/CH-2009-1158","article-title":"Nailfold capillaroscopy: specific features in Fabry disease.","volume":"42","author":"Wasik","year":"2009","journal-title":"Clin Hemorheol Microcirc"},{"key":"R22-13-20210226","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10545-013-9607-1","article-title":"Early cardiovascular remodelling in Fabry disease.","volume":"37","author":"Costanzo","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"R24-13-20210226","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrrheum.2012.96","article-title":"The pathogenesis, diagnosis and treatment of Raynaud phenomenon.","volume":"8","author":"Herrick","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R25-13-20210226","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jbspin.2006.07.002","article-title":"Raynauds phenomenon.","volume":"74","author":"Gayraud","year":"2007","journal-title":"Joint Bone Spine"},{"key":"R26-13-20210226","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s10067-005-0077-1","article-title":"Raynauds phenomenon: prevalence in an Italian population sample.","volume":"25","author":"De Angelis","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R28-13-20210226","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.autrev.2013.12.001","article-title":"Raynauds phenomenon: from molecular pathogenesis to therapy.","volume":"13","author":"Prete","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R29-13-20210226","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(00)05118-7","article-title":"Raynauds phenomenon.","volume":"357","author":"Block","year":"2001","journal-title":"Lancet"},{"key":"R30-13-20210226","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1024\/0301-1526\/a000159","article-title":"Qualitative and quantitative assessment of nailfold capillaries by capillaroscopy in healthy volunteers.","volume":"41","author":"Hoerth","year":"2012","journal-title":"VASA"},{"key":"R31-13-20210226","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00395-012-0311-3","article-title":"Pathologic endothelial response and impaired function of circulating angiogenic cells in patients with Fabry disease.","volume":"108","author":"Lorenzen","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"R32-13-20210226","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease.","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-13-20210226","doi-asserted-by":"crossref","first-page":"207573","DOI":"10.1155\/2013\/207573","article-title":"Vascular tortuosities of the upper eyelid: a new clinical finding in Fabry patient screening.","volume":"2013","author":"Michaud","year":"2013","journal-title":"J Ophthalmol"},{"key":"R34-13-20210226","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry.","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet Med"},{"key":"R35-13-20210226","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/cncr.22719","article-title":"Use of health-related and cancer-specific support groups among adult cancer survivors.","volume":"109","author":"Owen","year":"2007","journal-title":"Cancer"},{"key":"R36-13-20210226","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1523-5394.1999.07206.x","article-title":"Gender and cancer support group participation.","volume":"7","author":"Krizek","year":"1999","journal-title":"Cancer Pract"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:43:27Z","timestamp":1620960207000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201505040-00013"}},"subtitle":["A Cross-Sectional Study"],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":33,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000780","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}